Additionally, enhanced expression of GM-CSF was found in bevacizumab-resistant patients, suggesting that GM-CSF plays a role in recruiting MDSCs to suppress tumor immunity induced by hypoxia caused by anti-VEGF therapy. This evidence concerns the gene VEGFA and neoplasm.